Skip to content

Singular Genomics Systems, Inc.

CIK 0001850906

← back to feed
Revenue (TTM)
$2.05M
+280.5% YoY Q3 Oct 2024
Net Income (TTM)
−$85.43M
−4.3% YoY Q3 Oct 2024
EPS Diluted (TTM)
−$24.88
−1.6% YoY Q3 Oct 2024
Gross Margin
-47.0%
Q3 Oct 2024
Operating Margin
-4,507.2%
Q3 Oct 2024
Net Margin
-4,173.6%
Q3 Oct 2024
Free Cash Flow (TTM)
−$72.29M
Q3 Oct 2024
Cash
$52.62M
Q3 Oct 2024
Total Debt
$10.33M
Q3 Oct 2024
Shares Outstanding
2.51M sh
Q3 Oct 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings